Literature DB >> 15867125

Effect of using 2 throat swabs vs 1 throat swab on detection of group A streptococcus by a rapid antigen detection test.

Elias N Ezike1, Chokechai Rongkavilit, Marilynn R Fairfax, Ronald L Thomas, Basim I Asmar.   

Abstract

OBJECTIVE: To assess the effect of using 2 throat swabs vs 1 on rapid detection of group A streptococcus by the STREP A OIA MAX (hereafter, OIA MAX) test.
METHODS: Children aged 5 to 18 years with acute pharyngitis were randomized to 1 of 2 study groups. In group 1, one throat swab was obtained, streaked first on sheep blood agar, and then used for OIA MAX testing. In group 2, two throat swabs were obtained simultaneously. One swab was streaked first on sheep blood agar and then joined with the other swab for OIA MAX testing. In both groups, the pledgets in the collection-transport tube were incubated in Todd-Hewitt broth. A positive group A streptococcus culture either by sheep blood agar or Todd-Hewitt broth was confirmed by a latex agglutination test.
RESULTS: Three hundred sixty-three patients were enrolled, 177 in group 1 and 186 in group 2. Cultures were positive for group A streptococcus in 154 (42.4%) of 363 patients. The sensitivity and specificity of OIA MAX testing were 94.7% and 100.0%, respectively, in group 1, and 92.4% and 96.3%, respectively, in group 2. There was no statistical difference between the sensitivity, the specificity, and the predictive values of the OIA MAX test performed with 1 swab compared with those performed with 2 swabs (P>.10). There was no association between OIA MAX test sensitivity and the severity of pharyngitis as measured by the modified Centor criterion (history of fever, absence of cough, presence of pharyngeal or tonsillar exudates, and presence of cervical lymphadenopathy) scores.
CONCLUSIONS: The OIA MAX test yielded comparable sensitivity and specificity in both study groups. The use of 2 throat swabs instead of 1 swab did not increase the sensitivity of the OIA MAX test. The performance of the OIA MAX test did not depend on the severity of pharyngitis.

Entities:  

Mesh:

Year:  2005        PMID: 15867125     DOI: 10.1001/archpedi.159.5.486

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  6 in total

Review 1.  Rapid antigen detection test for group A streptococcus in children with pharyngitis.

Authors:  Jérémie F Cohen; Nathalie Bertille; Robert Cohen; Martin Chalumeau
Journal:  Cochrane Database Syst Rev       Date:  2016-07-04

2.  Immunoasssay chromatographic antigen test for rapid diagnosis of Group A beta hemolytic Streptococcus pharyngitis in children: A cross/ sectional study.

Authors:  S Noorbakhsh; A Tabatabaei; M Farhadi; Taj F Ebrahimi
Journal:  Iran J Microbiol       Date:  2011-06

Review 3.  Rapid antigen group A streptococcus test to diagnose pharyngitis: a systematic review and meta-analysis.

Authors:  Emily H Stewart; Brian Davis; B Lee Clemans-Taylor; Benjamin Littenberg; Carlos A Estrada; Robert M Centor
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

4.  STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

Authors:  Jérémie F Cohen; Daniël A Korevaar; Douglas G Altman; David E Bruns; Constantine A Gatsonis; Lotty Hooft; Les Irwig; Deborah Levine; Johannes B Reitsma; Henrica C W de Vet; Patrick M M Bossuyt
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

5.  An Agreement of Antigen Tests on Oral Pharyngeal Swabs or Less Invasive Testing With Reverse Transcription Polymerase Chain Reaction for Detecting SARS-CoV-2 in Adults: Protocol for a Prospective Nationwide Observational Study.

Authors:  Uffe Vest Schneider; Jenny Dahl Knudsen; Anders Koch; Nikolai Søren Kirkby; Jan Gorm Lisby
Journal:  JMIR Res Protoc       Date:  2022-05-04

Review 6.  Diagnostic Methods, Clinical Guidelines, and Antibiotic Treatment for Group A Streptococcal Pharyngitis: A Narrative Review.

Authors:  Zahid Mustafa; Masoumeh Ghaffari
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.